GlassScriptPhysician profile
Meghan Walters
NPI 1093411589
$795.65
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $155.12 | 2024 | |
| Novo Nordisk INC | $140.81 | 2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $113.13 | 2024 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $96.03 | 2024 | Otezla, Repatha, Prolia |
| Otsuka America Pharmaceutical, INC. | $71.87 | 2024 | Rexulti |
| Pfizer INC. | $68.99 | 2024 | |
| Lilly USA, LLC | $41.71 | 2024 | Zepbound, Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $40.48 | 2024 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $30.27 | 2024 | Cologuard Collection Kit |
| Medtronic, INC. | $24.11 | 2024 | Minimed 780g |
| Kowa Pharmaceuticals America, INC. | $13.13 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.